A quiet revolution is unfolding in crop protection. RNA interference, the cellular gene-silencing mechanism that earned a Nobel Prize in 2006, has finally crossed the threshold from laboratory proof of concept to registered, commercially available biopesticide. A new review published in Nature Plants by Stephen Fletcher, Neena Mitter and colleagues maps this pivotal moment, arguing that with technical feasibility now established, the decisive question is no longer whether RNAi-based biopesticides can work, but whether farmers, regulators and the public will embrace them. The recent registration of the first products targeting the Colorado potato beetle and the varroa mite marks the transition of a technology once confined to petri dishes into a practical tool for integrated pest management.
The underlying biology is elegant. RNA interference is a natural cellular defense pathway in which double-stranded RNA molecules are cut into small interfering RNAs that guide protein complexes to complementary messenger RNAs, triggering their degradation. When a double-stranded RNA molecule is designed to match a gene that is essential for a pest’s survival, feeding or topically applying that molecule can selectively shut down the target gene and kill or debilitate the pest without touching the crop itself. Because the sequence match must be precise, the approach offers a degree of specificity that broad-spectrum synthetic chemicals rarely achieve. The machinery is ancient and widespread: Dicer enzymes and Argonaute proteins, the core components of the silencing pathway, operate in insects, mites, nematodes, fungi and plants, which is precisely why the technology can in principle be aimed at such a diverse roster of agricultural enemies.
The scientific foundations were laid decades before anyone thought of spraying RNA on a field. Observations of virus-induced ring spot disease in the 1920s, co-suppression of genes in petunias in 1990 and quelling in Neurospora in 1992 all hinted at homology-dependent gene silencing. Andrew Fire and Craig Mello’s 1998 demonstration of potent and specific interference by double-stranded RNA in Caenorhabditis elegans unified these threads, and subsequent work identified Dicer as the enzyme that dices long double-stranded RNA and Argonaute2 as the catalytic engine of silencing. By 2007, researchers had shown that RNA interference could control coleopteran pests and that plant-mediated silencing could disable cotton bollworm detoxification genes. Cross-kingdom RNAi, in which fungal small RNAs hijack host plant machinery and plants dispatch small RNAs in extracellular vesicles to silence fungal virulence genes, revealed that this molecular arms race was already running between crops and their pathogens.
Two commercial milestones now anchor the field. A sprayable double-stranded RNA product targeting the proteasome subunit beta type-5 gene of the Colorado potato beetle, marketed as Calantha, became the first RNAi-based biopesticide registered for field use, with the US Environmental Protection Agency approving its product label in late 2023. More recently, a product called Norroa has been evaluated against Varroa destructor, the parasitic mite that devastates managed honey bee colonies worldwide. Laboratory and field trials have demonstrated toxicity of the dsRNA-based insecticide to the beetle, and studies of Norroa in managed hives suggest suppression of mite reproduction. These registrations matter because they demonstrate that regulators in at least one major jurisdiction are willing to assess and approve nucleic-acid-based crop protection products, opening a pathway that competitors can follow.
Yet the review’s authors are careful to frame adoption as an economic and social decision, not merely a technical one. They model farmer uptake as a return-on-investment calculation shaped by three levers: agricultural utility, meaning safe and reliable efficacy against pests and pathogens; regulatory reality, meaning the barriers that determine whether products actually reach the market; and social licence, meaning public perception and acceptance of a novel biotechnology. The backdrop makes the calculus favorable in principle. Pests and pathogens impose a staggering global burden on major food crops, pesticide use continues to climb, resistance to conventional chemistries is spreading through both established and newly emerging mechanisms, and regulatory restrictions are steadily withdrawing older synthetic actives from the market. Every withdrawn chemistry leaves a gap that RNAi-based products could fill, provided the cost-benefit ratio tips in their favor.
Delivering double-stranded RNA intact to the right cells remains the central technical challenge, and it is one where recent progress has been dramatic. RNA is notoriously fragile: nucleases in insect guts and on leaf surfaces degrade it rapidly, and some bacteria associated with plants actively secrete nucleases that chew up dsRNA before it can act. Different pests vary enormously in their sensitivity, with beetles generally responding well while many lepidopterans and aphids show weak responses linked to endosomal entrapment and rapid degradation. Nanotechnology offers a way through. Layered clay nanosheets known as BioClay have been shown to release RNA slowly on leaf surfaces for sustained protection against plant viruses, while liposome encapsulation, chitosan nanoparticles, graphene quantum dots and artificial membrane-chimeric nanovesicles have each improved delivery and efficacy in systems ranging from stink bugs to Fusarium head blight in wheat. Recent work even shows that foliar-applied double-stranded RNA is mobile within the plant and can transfer to pathogens to trigger silencing.
Designing the RNA sequence itself has become a computational science. A growing suite of bioinformatics tools now screens candidate double-stranded RNAs for efficacy and safety simultaneously. Platforms such as dsRIP, dsRNAEngineer, SIREN and dsRNAmax help researchers select target genes, design chimeric multi-target constructs and predict off-target complementarity against non-target organisms. This matters because off-target silencing correlates with the mismatch rate between the dsRNA and non-target messenger RNAs, so a well-designed 21-24 nucleotide stretch of sequence identity can be the difference between a selective product and an ecological liability. Computational risk assessment frameworks, including ecological and human health frameworks developed specifically for externally applied dsRNA biopesticides, formalize this screening into a pipeline that regulators can evaluate, and OECD consensus documents now outline considerations for both human health and environmental risk assessment of sprayed dsRNA products.
Environmental fate data have been reassuring so far. Studies of double-stranded RNA in agricultural soils and in sediment-water systems following over-water application show rapid degradation, consistent with the expectation that RNA does not persist in the environment the way persistent organic pollutants do. Vertebrate safety evaluations, including 28-day oral toxicity studies of small interfering RNAs and long dsRNA in mice, have found no adverse effects at relevant exposures, and computational analyses of crop transcriptomes help quantify any residual sequence complementarity with human genes. Resistance is the thornier long-term question. Researchers have deliberately selected dsRNA-resistant populations of Colorado potato beetle and western corn rootworm, demonstrating that resistance can evolve, although notably, dsRNA-resistant beetle larvae remained fully susceptible to small-molecule pesticides, suggesting RNAi and conventional chemistries could rotate as complementary modes of action rather than compete.
The most uncertain variable may be the least technical: social licence. A systematic review of public perceptions of RNAi-based biopesticides highlights that acceptance will hinge on how the technology is communicated, particularly around questions of safety, residues on food, and the simple fact that spraying a gene-silencing molecule sounds like genetic modification to many consumers, even though no organism’s genome is altered. Lessons from nanotechnology risk governance and from the fraught history of transgenic crops suggest that early, transparent engagement with the public and with ethical, legal and social discourses is essential. The authors also flag fragmented international regulatory harmonization as a brake on adoption: without global cohesion on how dsRNA products are assessed, developers face a patchwork of requirements that raises costs and delays market entry, particularly for smaller companies and for products aimed at minor crops.
What emerges from the review is a technology at an inflection point. The molecular machinery is understood, the delivery systems are maturing, the design tools are automated, the risk assessment frameworks are published, and two registered products have proven that the regulatory pathway exists. The remaining work is to make the economics work at scale, to align regulators across borders, and to earn the public trust that any agricultural biotechnology ultimately requires. If those levers move in the right direction, RNAi-based biopesticides could become a cornerstone of sustainable pest management, filling the market gaps left by withdrawn chemistries with a weapon that is as precise as a sequence and as biodegradable as the RNA it deploys.
Subject of Research: Adoption of RNA interference-based biopesticides for agricultural pest and pathogen control
Article Title: Advancing the adoption of RNA interference-based biopesticides
Article References: Fletcher, S., Gunasekara, S., Narva, K., De Neef, E., Ashworth, P., Jin, H., & Mitter, N. (2026). Advancing the adoption of RNA interference-based biopesticides. Nature Plants. https://doi.org/10.1038/s41477-026-02409-2
Image Credits: AI Generated
DOI: 10.1038/s41477-026-02409-2
Keywords: RNA interference, biopesticides, double-stranded RNA, crop protection, Colorado potato beetle, varroa mite, gene silencing, nanocarriers, pesticide resistance, regulatory harmonization, social licence, integrated pest management
Cite Scienmag News
APA
MLA
Chicago
Alan Morgan. (September 25, 2026). RNAi Biopesticides Move From Lab Curiosity to Field Reality as First Products Win Registration. Scienmag. https://scienmag.com/rnai-biopesticides-move-from-lab-curiosity-to-field-reality-as-first-products-win-registration/
Alan Morgan. “RNAi Biopesticides Move From Lab Curiosity to Field Reality as First Products Win Registration.” Scienmag, 25 September 2026, https://scienmag.com/rnai-biopesticides-move-from-lab-curiosity-to-field-reality-as-first-products-win-registration/. Accessed 25 September 2026.
Alan Morgan. “RNAi Biopesticides Move From Lab Curiosity to Field Reality as First Products Win Registration.” Scienmag. September 25, 2026. https://scienmag.com/rnai-biopesticides-move-from-lab-curiosity-to-field-reality-as-first-products-win-registration/
Copy citation
Download RIS
Tags: biopesticide registrationbiopesticidesColorado potato beetlecrop protectiondouble-stranded RNAenvironmentally friendly pest controlgene silencinggene-silencing technologyintegrated pest managementnanocarriersnatural pest control methodspest management solutionspesticide resistanceregulatory approval of biopesticidesregulatory harmonizationRNA interferenceRNA interference in agricultureRNAi biopesticidesRNAi for insect and mite controlsocial licencesustainable agriculture innovationstargeted pest gene suppressionvarroa mite
